Literature DB >> 24806483

Current advances in the fabrication of microneedles for transdermal delivery.

Sunaina Indermun1, Regina Luttge2, Yahya E Choonara1, Pradeep Kumar1, Lisa C du Toit1, Girish Modi3, Viness Pillay4.   

Abstract

The transdermal route is an excellent site for drug delivery due to the avoidance of gastric degradation and hepatic metabolism, in addition to easy accessibility. Although offering numerous attractive advantages, many available transdermal systems are not able to deliver drugs and other compounds as desired. The use of hypodermic needles, associated with phobia, pain and accidental needle-sticks has been used to overcome the delivery limitation of macromolecular compounds. The means to overcome the disadvantages of hypodermic needles has led to the development of microneedles for transdermal delivery. However, since the initial stages of microneedle fabrication, recent research has been conducted integrating various fabrication techniques for generating sophisticated microneedle devices for transdermal delivery including progress on their commercialization. A concerted effort has been made within this review to highlight the current advances of microneedles, and to provide an update of pharmaceutical research in the field of microneedle-assisted transdermal drug delivery systems.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hypodermic; Microneedle; Microscale fabrication techniques

Mesh:

Substances:

Year:  2014        PMID: 24806483     DOI: 10.1016/j.jconrel.2014.04.052

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  57 in total

1.  Skin drug permeability and safety through a vibrating solid micro-needle system.

Authors:  Ting-Ting Liu; Kai Chen; Qiao Wang
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

Review 2.  Harnessing the lymph node microenvironment.

Authors:  Natalie A O'Neill; Haleigh B Eppler; Christopher M Jewell; Jonathan S Bromberg
Journal:  Curr Opin Organ Transplant       Date:  2018-02       Impact factor: 2.640

Review 3.  Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation.

Authors:  Rebecca E M Lutton; Jessica Moore; Eneko Larrañeta; Stephen Ligett; A David Woolfson; Ryan F Donnelly
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

4.  3D-Printing of Functional Biomedical Microdevices via Light- and Extrusion-Based Approaches.

Authors:  Henry H Hwang; Wei Zhu; Grace Victorine; Natalie Lawrence; Shaochen Chen
Journal:  Small Methods       Date:  2017-12-19

Review 5.  Microneedle arrays for the treatment of chronic wounds.

Authors:  Lindsay Barnum; Mohamadmahdi Samandari; Tannin A Schmidt; Ali Tamayol
Journal:  Expert Opin Drug Deliv       Date:  2020-10-08       Impact factor: 6.648

Review 6.  Advances in immunotherapy delivery from implantable and injectable biomaterials.

Authors:  David G Leach; Simon Young; Jeffrey D Hartgerink
Journal:  Acta Biomater       Date:  2019-02-13       Impact factor: 8.947

Review 7.  An update on coating/manufacturing techniques of microneedles.

Authors:  Tamara N Tarbox; Alan B Watts; Zhengrong Cui; Robert O Williams
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

Review 8.  Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors.

Authors:  Anthony S Ham; Robert W Buckheit
Journal:  Ther Deliv       Date:  2015-02

Review 9.  Nucleic acid delivery into skin for the treatment of skin disease: Proofs-of-concept, potential impact, and remaining challenges.

Authors:  Michael Zakrewsky; Sunny Kumar; Samir Mitragotri
Journal:  J Control Release       Date:  2015-09-15       Impact factor: 9.776

Review 10.  Improving Vaccine and Immunotherapy Design Using Biomaterials.

Authors:  Michelle L Bookstaver; Shannon J Tsai; Jonathan S Bromberg; Christopher M Jewell
Journal:  Trends Immunol       Date:  2017-12-14       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.